Patients With Polycythemia Vera Achieve Long-Term Treatment Goals With Ropeginterferon Alfa-2b
Researchers sought to determine whether long-term ropeginterferon alfa-2b would have benefits in patients with PV compared with hydroxyurea or the best available treatment.